Veralox Therapeutics
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia (NCT05785819) | Veralox Therapeutics | 2023-09-26 |
| A Phase I Study of the Co-administration of VLX-1005 and Argatroban in Healthy Human Subjects (NCT05325346) | Veralox Therapeutics | 2022-03-07 |
| Phase I Study of VLX-1005 in Healthy Subjects (NCT04783545) | Veralox Therapeutics | 2021-03-24 |
Track Veralox Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.